Prices for lab monkeys surge on China biotech boom
More drugs entering middle or late-stage development drive up demand
More drugs entering middle or late-stage development drive up demand

Drugs developed in Asian nation are increasingly being used to seed US start-ups

Reforms, faster development and lower costs have turbocharged growth

FDA decision aligns with Trump administration’s effort to lower pharma costs by eliminating lab monkey requirement

Life sciences should be a natural place to look for growth

Global pharmaceutical companies are aggressively searching for new medicines in China

A shortage of late-stage capital pushes the biggest prizes into US hands